EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors

Jakob Heckel, Andres Martinez, Carsten Elger, Markus Haindl, Michael Leiss, Raphael Ruppert, Chris Williams, Jürgen Hubbuch, Tobias Graf

Molecular Therapy Methods & Clinical Development · 2023-12 · 31 · 101148

DOI: 10.1016/j.omtm.2023.101148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Methods & Clinical Development, 2023-12. Verfasst von Jakob Heckel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharma Technical Development Analytics, Roche Diagnostics GmbH, 82377 Penzberg, Germany. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno-associated viruses (rAAVs) are promising gene delivery vectors in the emerging field of in vivo gene therapies. To ensure their consistent quality during manufacturing and process development, multiple analytical techniques have been proposed for the characterization and quantification of rAAV capsids. Despite their indisputable capabilities for performing this task, current analytical methods are rather time-consuming, material intensive, complicated, and costly, restricting their suitability for process development in which time and sample throughput are severe constraints. To eliminate this bottleneck, we introduce here an affinity-based high-performance liquid chromatography method that allows the determination of the capsid titer and the full/empty ratio of rAAVs within less than 5 min. By packing the commercially available AAVX affinity resin into small analytical columns, the rAAV fraction of diverse serotypes can be isolated from process-related impurities and analyzed by UV and fluorescence detection. As demonstrated by both method qualification data and side-by-side comparison with AAV enzyme-linked immunosorbent assay results for rAAV8 samples as well as by experiments using additional rAAV2, rAAV8, and rAAV9 constructs, our approach showed good performance, indicating its potential as a fast, simple and efficient tool for supporting the development of rAAV gene therapies.

Schlagwörter

Stichwörter der Autor:innen

AAVadeno-associatedaffinity chromatographycapsid titerfluorescencegene therapyhigh-throughputprocess development

Autor:innen und Institutionen

  • Pharma Technical Development Analytics, Roche Diagnostics GmbH, 82377 Penzberg, Germany.
  • Gene Therapy Technical Development, Roche Diagnostics GmbH, 82377 Penzberg, Germany.
  • Institute of Process Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.

Zitieren

APA

Heckel, J., Martinez, A., Elger, C., Haindl, M., Leiss, M., Ruppert, R., Williams, C., Hubbuch, J., & Graf, T. (2023). Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors. Molecular Therapy Methods & Clinical Development, 31, 101148. https://doi.org/10.1016/j.omtm.2023.101148

Vancouver

Heckel J, Martinez A, Elger C, Haindl M, Leiss M, Ruppert R, et al. Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors. Molecular Therapy Methods & Clinical Development. 2023;31:101148. doi:10.1016/j.omtm.2023.101148

BibTeX
@article{Heckel2023,
  author = {Heckel, Jakob and Martinez, Andres and Elger, Carsten and Haindl, Markus and Leiss, Michael and Ruppert, Raphael and Williams, Chris and Hubbuch, Jürgen and Graf, Tobias},
  title = {Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors},
  journal = {Molecular Therapy Methods & Clinical Development},
  year = {2023},
  volume = {31},
  pages = {101148},
  doi = {10.1016/j.omtm.2023.101148}
}
Kostenlos starten →